Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Viking Thera
(NQ:
VKTX
)
62.94
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viking Thera
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
10 Health Care Stocks Whale Activity In Today's Session
May 22, 2023
Via
Benzinga
Pfizer Stock Jumps After Diabetes Drug Tops Ozempic In Weight Loss
May 22, 2023
Pfizer's diabetes drug led to faster weight loss than Novo Nordisk's Ozempic.
Via
Investor's Business Daily
Intercept Crashes As FDA Advisors Deliver The Likely Deathblow For Its Highly Watched NASH Drug
May 22, 2023
The FDA's advisors voted resoundingly against accelerated approval for obeticholic acid.
Via
Investor's Business Daily
Hero or Zero? 3 High-Risk Biotech Stocks to Make You Rich … or Broke.
May 22, 2023
These biotech companies are swinging for the fences. They may hit homers, they may strike out. But you'll definitely want to watch them.
Via
InvestorPlace
7 Stocks That Wall Street Analysts Are Loving in May
May 21, 2023
Though not perfect, an analyst rating can indicate where institutional investor sentiment lies; here are seven stocks that analysts love.
Via
InvestorPlace
Why Viking Therapeutics Stock Is Buckling Today
May 18, 2023
The biotech's shares can't escape the broader downward trend among its peer group today.
Via
The Motley Fool
What 17 Analyst Ratings Have To Say About Viking Therapeutics
May 17, 2023
Via
Benzinga
Why Viking Therapeutics Stock Bolted Higher Today
May 16, 2023
The biotech's midstage NASH candidate passed another key hurdle.
Via
The Motley Fool
Viking Therapeutics Outperforms Expectations: Analyst Increases Price Target Following Successful VK2809 Trial
May 16, 2023
Ligand Pharmaceuticals Incorporated's (NASDAQ: LGND) partner Viking Therapeutics Inc (NASDAQ: VKTX) announced positive topline results from its Phase 2b trial of VK2809 in
Via
Benzinga
Is Novo Nordisk Stock a Screaming Buy Right Now?
May 16, 2023
The drugmaker's shares have crushed the broader markets over the past two years. Can it keep up this blistering momentum?
Via
The Motley Fool
Why Top 1% Biotech Viking Therapeutics Is At The Brink Of A Record High
May 16, 2023
The company is working on a treatment for nonalcoholic steatohepatitis, or NASH.
Via
Investor's Business Daily
Why Viking Therapeutics Stock Is Trading Higher Tuesday
May 16, 2023
Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Tuesday after the company announced positive top-line results from a Phase
Via
Benzinga
Why Viking Therapeutics Stock Wobbled Today
May 09, 2023
The biotech's shares dipped along with the broader markets in early-morning trading today.
Via
The Motley Fool
Why Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics Were on the Move Today
May 01, 2023
These three biotech stocks were on the volatile side today.
Via
The Motley Fool
Why Viking Therapeutics Stock Briefly Popped Today
April 27, 2023
The biotech's shares rose briefly this morning following a sizable price target revision by an investing firm.
Via
The Motley Fool
Expert Ratings for Viking Therapeutics
April 25, 2023
Via
Benzinga
Earnings Preview For Viking Therapeutics
April 25, 2023
Via
Benzinga
Eli Lilly's Diabetes Newcomer, Mounjaro, Just Blew Sales Projections Out Of The Water
April 27, 2023
Mounjaro topped first-quarter sales expectations by more than $100 million.
Via
Investor's Business Daily
Earnings Scheduled For April 26, 2023
April 26, 2023
Companies Reporting Before The Bell • Teck Resources (NYSE:TECK) is expected to report quarterly earnings at $1.36 per share on revenue of $3.11 billion.
Via
Benzinga
3 Top Biotech Stocks Defying the Bear Market
April 25, 2023
All three companies have therapies with strong sales potential.
Via
The Motley Fool
Here are 2 Top Drug Makers Leading the Way in Weight Loss Drugs
April 17, 2023
The topic of weight loss drugs has been making recent headlines. The positive phase 1 clinical trial for Viking Therapeutics Inc. (NASDAQ: VKTX) GLP-1 treatme
Via
MarketBeat
Why Shares of Viking Therapeutics Skyrocketed This Week
March 30, 2023
The clinical-stage stock nearly doubled in price.
Via
The Motley Fool
BTIG Maintains Buy Rating for Viking Therapeutics: Here's What You Need To Know
March 29, 2023
Via
Benzinga
Novo Nordisk Surges To Another Record As Obesity Drugs Drive Higher Outlook
April 13, 2023
Demand for Wegovy and Ozempic prompted Novo to raise its full-year outlook.
Via
Investor's Business Daily
Red-Hot Obesity-Drug Maker Novo Nordisk Soars To Record On A $725 Million Deal
April 12, 2023
Novo Nordisk is already a leader in obesity treatment with Saxenda and Wegovy.
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
April 07, 2023
Via
Benzinga
5 Best Stocks to Buy in April
April 01, 2023
These powerful trends should yield stellar returns for investors in April and beyond.
Via
The Motley Fool
Stock Market Rallies On Micron, Alibaba, Lululemon, Ebbing Bank Fears: Weekly Review
March 31, 2023
The stock market rallied on ebbing bank fears and positive news from Micron, Alibaba and Lululemon Athletica.
Via
Investor's Business Daily
RH, Semtech And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
March 30, 2023
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. Semtech Corporation (NASDAQ: SMTC) shares dipped 12.7% to $28.00 in...
Via
Benzinga
Tesla, RH, Rumble, Stem, Viking Therapeutics: Why These 5 Stocks Are Drawing Investors' Attention Today
March 29, 2023
Via
Benzinga
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.